CLL registry for patients 18 and older
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This registry collects information over time from people with CLL to better understand the disease and its treatment. It does not test any new drugs or procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with chronic lymphocytic leukemia (CLL).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from people with chronic lymphocytic leukemia (CLL) to better understand the disease over time. If you join, you would share your medical and health details and give consent to be included in the registry.
This study looks at what it’s like to live with chronic lymphocytic leukemia while participating in a clinical research protocol. It may help researchers understand patient experiences and improve how future trials are run.
This study aims to learn more about chronic lymphocytic leukemia (CLL) and closely related conditions. It may help researchers better understand who gets CLL and how it behaves over time, which can improve future care.
This is a study that looks back and forward at people diagnosed with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or a related early condition called MBL. It aims to improve how these conditions are recognized and managed over time in Italy.
This registry tracks people with non-Hodgkin lymphoma who are starting a new line of systemic therapy. It collects information to better understand how treatments work in real life, and optionally asks you to fill out surveys about your symptoms and quality of life.
This study is a cancer registry that collects information from people with lymphoma, Hodgkin disease, or myeloma. It helps researchers understand these cancers better by using real-world patient data.
Hear when a new Chronic Lymphocytic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.